Abstract:Nanotechnology has greatly impacted our daily life and has certainly yielded many promising benefits. Titanium dioxide nanoparticles (TiO2-NPs) are among those produced on a large industrial scale that have found many practical applications in industry and daily life. Due to their presence in products such as food, cosmetics, sunscreens, medications, paints or textiles, contact with TiO2-NPs in our daily life is inevitable. The small size, together with the corresponding large specific surface area, make nanoparticles able to penetrate through cellular barriers and reach various parts of the body through different routes of exposure, including inhalation, injection, dermal penetration, and gastrointestinal tract absorption. Furthermore, after long-term exposure, the TiO2-NPs could accumulate in tissues leading to chronic diseases. This raises serious doubts about their potentially harmful effects on human health. In the past, TiO2-NPs have been considered inert, however, many in vitro studies have shown that they were cyto- and genotoxic, leading to the production of reactive oxygen species (ROS) and to the activation of signaling pathways involved in inflammation and cell death. Several in vivo studies have also demonstrated that TiO2-NPs, once in the bloodstream, could reach and accumulate in important organs causing toxic effects. Very recently, the International Agency for Research on Cancer (IARC) has classified these nanoparticles as possibly carcinogenic to humans. In this survey, we summarize the latest advances in acknowledging the toxicity and safety of TiO2-NPs. Since the literature is often controversial, further studies are still needed to define the risk/benefit ratio of using these nanoparticles. Overall, the data herein reported are critical for assessing human risk after exposure to TiO2-NPs.

Genotoxicity of TiO2 Nanoparticles in Four Different Human Cell Lines (A549, HEPG2, A172 and SH-SY5Y)

Advances in Genotoxicity of Titanium Dioxide Nanoparticles in Vivo and in Vitro

Genotoxic Evaluation of Titanium Dioxide Nanoparticles in Vivo and in Vitro

Analysis of cytotoxicity and genotoxicity in a short-term dependent manner induced by a new titanium dioxide nanoparticle in murine fibroblast cells

Genotoxicity and Gene Expression Analyses of Liver and Lung Tissues of Mice Treated with Titanium Dioxide Nanoparticles.

Investigation of genotoxic and cytotoxic effects of micro- and nanosized titanium dioxide in six organs of mice in vivo

Titanium Dioxide Nanoparticles: a Risk for Human Health?

Toxicity Assessment of Six Titanium Dioxide Nanoparticles in Human Epidermal Keratinocytes.

Genotoxicity Evaluation of Titanium Dioxide Nanoparticles Using the Ames Test and Comet Assay.

Titanium Dioxide Nanoparticles: a Review of Current Toxicological Data

Cytotoxicity of Titanium Dioxide Nanoparticles in Mouse Fibroblast Cells

Cytotoxicity of Titanium Dioxide Nanoparticles Differs in Four Liver Cells from Human and Rat

TiO2-NPs Toxicity and Safety: An Update of the Findings Published over the Last Six Years

DNA Oxidative Damage as a Sensitive Genetic Endpoint to Detect the Genotoxicity Induced by Titanium Dioxide Nanoparticles

Analysis of the Characteristics and Cytotoxicity of Titanium Dioxide Nanomaterials Following Simulated In Vitro Digestion

Progress of in Vivo Studies on the Systemic Toxicities Induced by Titanium Dioxide Nanoparticles

Nanotoxicity of TiO2 nanoparticles to erythrocyte in vitro

The potential health challenges of TiO2 nanomaterials

Rethinking Nano‐TiO 2 Safety: Overview of Toxic Effects in Humans and Aquatic Animals

In vitro evaluation of the toxicity and underlying molecular mechanisms of Janus Fe3 O4 -TiO2 nanoparticles in human liver cells

In Vitro Hepatotoxic and Neurotoxic Effects of Titanium and Cerium Dioxide Nanoparticles, Arsenic and Mercury Co-Exposure